TRI 14.3% 2.4¢ trivarx ltd

Ann: Medibio Submits FDA De Novo Application, page-13

  1. 1,442 Posts.
    lightbulb Created with Sketch. 864
    Great announcement, MEB has all the ingredients of a stock going much higher from here.

    Such a low market cap and we are now formally on the cusp of FDA approval for a revolutionary monitoring and diagnosis aid of Depression.

    Medibio have already met with key members of the FDA, considering the positive trial results this seems to be de-risked significantly.

    Looking forward to the consumer app launch and the further corporate commercial developments.
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.